✦ LIBER ✦
Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metaboliteN-desmethyl-imatinib be developed?
✍ Scribed by Peggy Gandia, Cécile Arellano, Thierry Lafont…
- Book ID
- 120776583
- Publisher
- Springer
- Year
- 2012
- Tongue
- English
- Weight
- 411 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.